Previous Article | Next Article ![]()
Journal of Virology, May 2008, p. 4413-4419, Vol. 82, No. 9
0022-538X/08/$08.00+0 doi:10.1128/JVI.02141-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Unité des Rétrovirus Endogènes et Eléments Rétroïdes des Eucaryotes Supérieurs, CNRS UMR 8122, Institut Gustave Roussy, Villejuif, F-94805 France,1 Université Paris-Sud, Orsay, F-91405 France,2 Laboratoire de Réplication de l'ADN et Ultrastructure du Noyau, FRE 2937, Institut André Lwoff, Villejuif, F-94801 France3
Received 28 September 2007/ Accepted 8 February 2008
|
|
|---|
|
|
|---|
10 copies in the C57BL/6 genome) and the highly reiterated Mus musculus type D/early transposon (MusD/ETn) ERVs (
350 copies), whose particles have recently been demonstrated to assemble in a strictly intracellular location (28), as observed for type B/D retroviruses. A second large family of ERVs includes the intracisternal A-type particle (more than 1,000 copies) and intracisternal A-type particle-related, envelope-encoding elements (
250 copies), which are also phylogenetically close to betaretroviruses but can be distinguished from the latter by the site of particle assembly, which is not within the cell cytoplasm but rather at the level of membranes, where budding occurs, as observed for type C retroviruses. Assembly takes place at the endoplasmic reticulum membrane in the case of intracisternal A-type particles (10, 15, 19) and at the cell plasma membrane in the case of intracisternal A-type particle-related, envelope-encoding elements (28a). A third large family of elements is composed of the rather atypical murine ERV-L (MuERV-L) elements, which are among the most ancient ERVs present in mammals, with
500 full-length copies dispersed throughout the mouse genome (3, 4). MuERV-L elements are unrelated to any known present-day infectious retroviruses at the levels of both their sequence (although their pol gene is distantly related to that of foamy viruses [9]) and the morphology of the virus-like particles they encode. We have recently demonstrated that they correspond to the epsilon particles previously reported to occur in two-cell mouse embryos (29), with a unique morphology among retroviral elements. Finally, the most diverse group of mouse ERVs belongs to the gammaretroviruses. Rather paradoxically, it includes both a very well-characterized family of elements, namely, the murine leukemia viruses (MLVs), and a series of little-studied elements, including murine retrovirus-related DNA sequences (30), murine retrovirus Y-associated element (13), MuERV-C (37), Mus musculus ERV (8), and murine retrovirus using tRNAGln (GLN) (18, 25). These are present at high copy numbers, with only the last two families showing copies with coding-competent env genes (reference 12 and data not shown). Whereas MmERV is closely related to Mus dunni endogenous virus, a well-characterized infectious ERV from Mus dunni (7, 34, 35), the GLN family has no known infectious close relative. This family was thus characterized to tentatively identify functional proviral copies and to investigate their structure and life cycle.
![]() View larger version (26K): [in a new window] |
FIG. 1. Structure and phylogeny of GLN elements. (A) Genomic organization of a full-length coding-competent GLN element, with the LTRs (in dark gray) flanking three complete ORFs homologous to the retroviral gag, pro-pol, and env genes (in light gray). A primer binding site (PBS) complementary to tRNAGln and a polypurine tract (PPT) can be identified, as indicated. The structures of the full-length and spliced viral transcripts are indicated (SD, splice donor site; SA, splice acceptor site). (B) Phylogeny of retroviruses, based on their RT domains. The tree was determined by the neighbor-joining method using the seven blocks of conserved residues found in the RT domains of all retroelements and was rooted using non-LTR retrotransposons. All sequences are readily accessible from GenBank and previous reports (e.g., reference 21). Percent bootstrap values, obtained from 1,000 replicates, are indicated. The retroviruses "endogenized" in the mouse genome are marked with asterisks. The seven retroviral families are indicated on the right. PFV, primate foamy virus; MuERV-L, murine ERV-L element; MuRRS, murine retrovirus-related DNA sequence; MuRV-Y, murine retrovirus Y-associated element; MmERV, Mus musculus ERV; GALV, gibbon ape leukemia virus; FeLV, feline leukemia virus; WDSV, walleye dermal sarcoma virus; ALV, avian leukosis virus; MMTV, mouse mammary tumor virus; JSRV, jaagsiekte sheep retrovirus; MusD, Mus musculus type D element; MPMV, Mason-Pfizer monkey virus; HIV-1, human immunodeficiency virus type 1; HTLV-1, human T-cell leukemia virus type-1. (C) In silico identification of the full-length, coding-competent GLN copies contained in the C57BL/6 genome. A Blast search was carried out with the NCBI m36 Mouse Assembly (April 2006 release).
|
|
|
|---|
The plasmid containing the GLN-2 copy was obtained by cloning into pBR322 the complete proviral DNA contained in a HindIII-SpeI fragment from bacterial artificial chromosome RP23-356G7 DNA (nucleotides [nt] 184912 to 193326). The defective neo-marked GLN element was obtained by inserting the blunt-ended HindIII-XhoI fragment from pSVneo* (14) into the GLN-2 plasmid, between the SnaBI and BlpI sites of the env gene (nt 6273 and 7795, respectively), and by further deleting an internal 4,568-bp gag-pro-pol fragment (from nt 1238 to 5805) upon digestion of the above-mentioned plasmid with AleI and religation.
Cell culture, pseudotyping, and infectivity assays. Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (VWR International), 100 µg/ml streptomycin, and 100 U/ml penicillin.
HeLa cells expressing mSMIT1 or mCAT1 (or control HeLa cells) were obtained by infection, followed by G418 selection with neo-containing MLV-derived expression vectors for mCAT1 (SFEV-mCAT1-neo) or mSMIT1 (MPEV-mSMIT1-neo) or with a control vector (MPEV-neo) (17, 26).
MLV and simian immunodeficiency virus (SIV) pseudotypes containing GLN, amphotropic-MLV, or ecotropic-MLV (Moloney MLV [MoMLV]) envelope (Env) proteins (or no Env protein for the negative control) were produced by cotransfecting 7.5 x 105 293T cells with 0.5 µg of the corresponding Env expression vector (or pcDNA3 for the negative control), 2.25 µg of vectors encoding the retroviral proteins (except the envelope) of MLV or SIV (23), and 2.25 µg of the corresponding defective retroviral vectors (pMFGsnlslacZ [16] or RqSA [22], both marked with a β-galactosidase reporter gene, by calcium phosphate precipitation (MBS transfection kit; Stratagene). M813-MLV recombinant pseudotypes were produced by cotransfecting 293T cells with 2.75 µg of an MLV retroviral vector containing the 5' domain of the M813 env gene (encompassing the receptor binding domain, Mo-M813 [26]) and 2.25 µg of pMFGsnlslacZ. Target cells were seeded in 24-well plates the day prior to infection. Supernatants from transfected 293T cells were harvested 48 h posttransfection, filtered through 0.45-µm-pore-size polyvinylidene difluoride membranes, supplemented with Polybrene (4 µg/ml), and added to the target cells, followed by spinoculation at 1,200 x g for 2 h 30 min at 25°C. After an additional 60-h incubation period, viral titers were determined by in situ X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) staining of target cells and quantification of LacZ-positive (LacZ+) CFU.
To assay for GLN infectivity, 293T cells were cotransfected with the defective neo-marked GLN reporter and the wild-type GLN-2 cloned provirus (or pBR322 as a control plasmid). Mouse 3T3 (WOP) cells were infected with the particles released into the transfected 293T cell supernatant. After removal of the supernatant and incubation in regular medium for 72 h at 37°C, 3T3 (WOP) cells were split into 100-mm dishes (5 x 105 cells per dish), allowed to settle for 24 h, and subjected to G418 selection. G418r foci were fixed, stained, and counted.
RT assay activity and detection of viral RNA in cell supernatants. Supernatants of 293T cells were harvested 48 h posttransfection, centrifuged for 5 min at 1,500 rpm, filtered through a 0.45-µm-pore-size polyvinylidene difluoride membrane, and used for a product-enhanced reverse transcriptase (PERT) assay (27) or for detection of GLN viral RNA.
For the PERT assay, the RT contained in 2.5 µl of supernatant was used to reverse transcribe 0.3 µg of MS2 phage RNA previously annealed to 16 pmol of RT-1 primer (5'-CACAGGTCAAACCTCCTAGGAATG-3'). cDNA synthesis was then assayed using 1/50 of the RT reaction mixture as a template for a 25-cycle PCR conducted with RT-1 and RT-2 (5'-TCCTGCTCAACTTCCTGTCGAG-3') primers, using Tth polymerase (Promega), leading to the amplification of a 112-bp fragment.
For detection of GLN viral RNA, RNAs contained in 30 µl of supernatant were purified using the RNeasy Microkit (Qiagen). One-fourth of an RT mixture from a reaction run with the GLN-RT primer (5'-CTGGTCCTTCCTGAAAAACA-3') was then used as a template for a 30-cycle PCR conducted with GLN-F (5'-TGTGTAAGTCCAGACGCAGA-3') and GLN-R (5'-CCAACCTACTCCAAAAACAG-3') primers, leading to the amplification of a 239-bp fragment.
Electron microscopy. For ultrastructural studies, transfected 293T cells were fixed in phosphate buffer, pH 7.2, 1.6% glutaraldehyde for 1 h and postfixed in 0.1 M cacodylate buffer, 1% osmium tetroxyde for 2 h. After being rinsed for 5 min in water and 15 min in 0.1 M cacodylate buffer, the cells were transferred to 0.2 M cacodylate buffer for 30 min. The cells were washed in 30% methanol for 10 min, stained in 2% uranyl acetate in 0.1 M cacodylate buffer-30% methanol for 1 h, and washed in 30% methanol. The cells were then dehydrated through a graded ethanol series and embedded in Epon 812. Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a Zeiss 902 microscope at 80 kV.
|
|
|---|
A GLN copy with a functional env gene. As illustrated in Fig. 2A, the structural organization of the GLN env is canonical, with a signal peptide at the N-terminal end and an R-X-(K/R)-R consensus cleavage site for the cellular furin protease that splits the Env protein into the surface (SU) and TM subunits, a hydrophobic fusion domain at the N-terminal end of the TM subunit, and a hydrophobic transmembrane anchor domain. To experimentally characterize the Env glycoproteins of the three coding-competent GLN copies, we first cloned the corresponding ORFs into a cytomegalovirus promoter-driven expression vector, starting from the env initiation codon to the end of the 3' LTR. The functionality of the GLN env was then assayed by pseudotyping. To do so, human 293T cells were cotransfected with expression vectors for the retroviral proteins (except Env) from a gammaretrovirus (MLV) or a lentivirus (SIV), a corresponding lacZ gene-marked defective retroviral vector, and the above-mentioned expression vector for the GLN env gene to be tested (or an empty vector as a negative control). Then, the pseudotyped virions produced in the supernatant of the transfected cells were assayed for infectivity on test target cells. Among the three env genes tested, only one was found to be positive in the assay, namely, that from GLN-2. Interestingly, infection could be detected using either type of viral core, with viral titers in the range of 100 to 1,000 LacZ+ CFU per ml, but was found only with mouse cells as targets (Fig. 2C). No infection events were detected with cells from other rodents, such as rats or hamsters, or with human cells, such as the 293T cells, which harbor the Pit1 receptor for GaLV and 10A1-MLV, as well as the Pit2 and Syg1 receptors for the ampho-, xeno-, and polytropic (MCF247) MLV (reference 32 and data not shown). Such a cell tropism, which classifies the GLN Env protein as ecotropic, has previously been found for several MLV strains (e.g., MoMLV) and for two murine ERVs, namely, HEMV in Mus spicilegus (32) and M813-MLV in Mus cervicolor (26), with the last two sharing the same receptor (17, 32). Despite severe sequence divergence between GLN and MLV Env proteins, even in the receptor binding domain (46% and 37% sequence homology between that of GLN and that of the ecotropic MoMLV and M813-MLV, respectively), we investigated whether GLN elements could recognize one of the receptors for these ecotropic retroviruses, i.e., mCAT1 (1) or mSMIT1 (17). To this end, we assayed whether expression of the mCAT1 or mSMIT1 receptor could confer on cells susceptibility to viral pseudotypes bearing the GLN Env glycoprotein. Nonpermissive human HeLa cells were first stably transduced by infection, followed by G418 selection, with neo-containing MLV-derived expression vectors for mCAT1 (SFEV-mCAT1-neo), mSMIT1 (MPEV-mSMIT1-neo), or a control vector (MPEV-neo) (17, 26). These receptor-expressing HeLa cells were then infected with various pseudotypes: MLV pseudotypes with the GLN Env glycoprotein, the amphotropic or ecotropic MLV Env glycoproteins as controls, and a M813-MLV pseudotype in which the N-terminal Env sequence is derived from M813 (26). As illustrated in Fig. 3, neither mCAT1 nor mSMIT1 confers susceptibility to GLN Env, although they do confer susceptibility to MoMLV Env and M813-MLV Env, respectively, indicating that GLN elements recognize a third kind of mouse ecotropic receptor.
![]() View larger version (58K): [in a new window] |
FIG. 2. Characterization of the GLN Env glycoprotein. (A) Schematic structure, hydrophobicity profile, and primary sequence of the GLN-2 Env protein. The SU and TM subunits are delineated, with a canonical furin cleavage site (RSKR) between the two subunits indicated in red. The hydrophobic signal peptide and fusion peptide and the transmembrane domain are shaded in gray. The CWLC motif (highlighted in black) and the putative immunosuppressive domain (ISU) (underlined) are indicated. (B) Infectivity assay of MLV particles pseudotyped with the GLN Env proteins. Supernatants of human 293T cells cotransfected with an expression vector for the MLV core proteins, a lacZ gene-marked defective retroviral vector, and an expression vector for the GLN-1, -2, or -3 Env protein, or a control plasmid (no env), was used to infect murine 3T3 (WOP) target cells. Infection events were detected by X-Gal staining of target cells. (C) Cell tropism of GLN-2 Env. The infectivities of MLV or SIV cores pseudotyped with the GLN-2 Env were determined using human, mouse, rat, hamster, or dog cell lines (the mouse MCA cells are from C3H mice, 3T3 [WOP] cells from NIH/Swiss mice, and LOK cells from 129/B6/DBA2 mice). Viral titers, corresponding to the number of LacZ+ CFU/ml of supernatant, are indicated as follows: –, <10; +, 100 to 1,000.
|
![]() View larger version (26K): [in a new window] |
FIG. 3. The GLN Env recognizes an unkown ecotropic receptor. Infectivities of MLV cores pseudotyped with either an MLV amphotropic (Ampho) Env, an MLV ecotropic (Eco) Env, an M813-derived Env (M813), or the GLN-2 Env (GLN) were assayed as in Fig. 2B. 3T3 (WOP) cells and human HeLa cells stably transduced with mSMIT1, mCAT1, or a control plasmid were used as target cells. Viral titers were determined by counting the LacZ+ CFU/ml of supernatant (the means of three independent experiments, with standard deviations, are shown). The arrows indicate the absence of LacZ+ foci.
|
![]() View larger version (19K): [in a new window] |
FIG. 4. GLN encodes infectious retroviral particles. (A) Analysis of GLN particles in cell supernatants. The supernatant of 293T cells transfected with the GLN-2 copy or a control plasmid was harvested 48 h posttransfection and assayed for RT activity (using the sensitive PERT assay described in reference 27, resulting in the amplification of a 112-bp DNA product) and for GLN viral RNA (using an RT-PCR assay on RNA extracted from the cell supernatant, resulting in the amplification of a 239-bp DNA product corresponding to part of the gag gene). (B) Infectivity assay of the GLN viral particles. Supernatant of 293T cells cotransfected with the neo-marked defective GLN-2 reporter (in which a backward neo resistance gene is introduced into a partly deleted env gene, with the gag-pro-pol genes further inactivated by a large internal deletion) and the full-length GLN-2 provirus or a control plasmid was harvested 48 h posttransfection and used to infect 3T3 (WOP) target cells. Infection events were detected upon G418 selection of the target cells, and viral titers were quantified by counting the G418r clones per milliliter of supernatant (the means of three independent experiments, with standard deviations, are shown).
|
![]() View larger version (58K): [in a new window] |
FIG. 5. Morphology of the GLN viral particles. Shown is electron microscopy of 293T cells transfected with GLN-2 or MoMLV. (a) GLN particles assembling and budding at the plasma membrane. (b) High magnification of mature extracellular GLN particles. (c) Morphological similarities between immature (top) and mature (bottom) GLN and MoMLV viral particles. Scale bars, 100 nm.
|
GLN-related sequences have also been detected by Southern blotting experiments performed on the genomic DNAs from a large set of Mus species (in those cases, at a high copy number), as well as from other rodents, including woodchuck, ground squirrel, hamster, gerbil, and rat (18, 25). Consistently, an in silico search that we performed in rat genome databases identified about 15 GLN-related copies, clearly belonging to the GLN family but much more degenerate, and less numerous, than in the mouse, with no full-length coding-competent copy. Taking the data together, it is thus likely that the GLN progenitor entered the rodent germ line prior to the Mus/Rattus split (i.e., >15 million years ago) (31)—and possibly even much earlier, before the radiation of Muridae—with amplification bursts then occurring, especially in the mouse genome. Being infectious, the GLN elements have most probably amplified by reinfection, and not by intracellular retrotransposition, of the germ line, as was the case in humans for the human ERV HERV-K(HML2) (2, 11).
This work was supported by the CNRS, by a grant from the Ligue Nationale contre le Cancer (Equipe Labellisée), and by a fellowship from the Association pour la Recherche sur le Cancer to D.R.
Published ahead of print on 20 February 2008. ![]()
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»